Related Experiment Video

Updated: Oct 9, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses

P M Moriarty1, C A Gibson

  • 1Lipid, Atherosclerosis, and Metabolic Clinic, University of Kansas Medical Center, 1336 KU Hospital, 3901 Rainbow Boulevard, Kansas City, KS 66160-7374, USA. pmoriart@kumc.edu

Current Atherosclerosis Reports
|March 20, 2001
PubMed

Insights

Low-density lipoprotein (LDL) apheresis offers significant clinical benefits for patients with severe hypercholesterolemia, potentially stabilizing arterial lesions and improving outcomes. This review explores its impact and broader applications in cardiovascular disease management.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Vascular Medicine

Background:

  • Refractory hypercholesterolemia poses a significant risk for cardiovascular events.
  • Traditional lipid-lowering therapies may be insufficient for certain patient groups.
  • Low-density lipoprotein (LDL) apheresis is an established extracorporeal procedure for severe lipid disorders.

Purpose of the Study:

  • To review the clinical impact and benefits of LDL apheresis in refractory hypercholesterolemia.
  • To explore mechanisms beyond arterial lesion stabilization contributing to clinical improvement.
  • To discuss the potential of lipid apheresis for broader patient populations.

Main Methods:

  • Review of existing investigations and clinical studies on LDL apheresis.
  • Analysis of data demonstrating clinical benefits and outcomes.
  • Exploration of proposed mechanisms of action.

Main Results:

  • LDL apheresis demonstrates significant clinical benefits in patients with refractory hypercholesterolemia.
  • Evidence supports the stabilization or regression of arterial lesions.
  • Other mechanisms contributing to clinical improvement are highlighted.

Conclusions:

  • LDL apheresis is a valuable therapeutic option for severe hypercholesterolemia.
  • The procedure offers benefits beyond direct lipid reduction, impacting cardiovascular health.
  • Potential applications may extend to patients with less severe hypercholesterolemia and premature coronary heart disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...